Evidence map›Paper›PMID 41696468›Full record

ArticleFrontiers in psychiatry2026

Mapping the network structure of anxiety, depression, and sleep symptoms in patients with polycystic ovary syndrome.

Shaojing Li, Yuhong Zhang, Xiangze Tang, Meilian Deng, Hong Luo, Yun Chen

Abstract read
In one paragraph

Article in Frontiers in psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Shaojing LiDepartment of Obstetrics and Gynecology, Guangdong Provincial Key Laboratory of Major Obstetric Diseases, Guangdong Provincial Clinical Research Center for Obstetrics and Gynecology, Guangdong-Hong Kong-Macao Greater Bay Area Higher Education Joint Laboratory of Maternal-Fetal Medicine, The Third Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.
Yuhong ZhangDepartment of Obstetrics and Gynecology, Guangdong Provincial Key Laboratory of Major Obstetric Diseases, Guangdong Provincial Clinical Research Center for Obstetrics and Gynecology, Guangdong-Hong Kong-Macao Greater Bay Area Higher Education Joint Laboratory of Maternal-Fetal Medicine, The Third Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.
Xiangze TangDepartment of Obstetrics and Gynecology, Guangdong Provincial Key Laboratory of Major Obstetric Diseases, Guangdong Provincial Clinical Research Center for Obstetrics and Gynecology, Guangdong-Hong Kong-Macao Greater Bay Area Higher Education Joint Laboratory of Maternal-Fetal Medicine, The Third Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.
Meilian DengDepartment of Obstetrics and Gynecology, Guangdong Provincial Key Laboratory of Major Obstetric Diseases, Guangdong Provincial Clinical Research Center for Obstetrics and Gynecology, Guangdong-Hong Kong-Macao Greater Bay Area Higher Education Joint Laboratory of Maternal-Fetal Medicine, The Third Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.
Hong LuoDepartment of Obstetrics and Gynecology, Guangdong Provincial Key Laboratory of Major Obstetric Diseases, Guangdong Provincial Clinical Research Center for Obstetrics and Gynecology, Guangdong-Hong Kong-Macao Greater Bay Area Higher Education Joint Laboratory of Maternal-Fetal Medicine, The Third Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.
Yun ChenDepartment of Obstetrics and Gynecology, Guangdong Provincial Key Laboratory of Major Obstetric Diseases, Guangdong Provincial Clinical Research Center for Obstetrics and Gynecology, Guangdong-Hong Kong-Macao Greater Bay Area Higher Education Joint Laboratory of Maternal-Fetal Medicine, The Third Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Patients with polycystic ovary syndrome (PCOS) often experience anxiety, depression, and sleep problems in addition to endocrine and metabolic abnormalities, which may adversely affect their quality of life and disease progression. However, research on the co-occurrence patterns and interconnections among these psychological symptoms in PCOS remains limited. This study applied network analysis to explore the relationships among anxiety, depression, and sleep problems in women with PCOS, aiming to identify key symptom nodes and provide evidence for targeted psychological interventions. Methods: This retrospective study included 1,068 patients with PCOS. Anxiety, depression, and sleep problems were assessed using the Generalized Anxiety Disorder Scale (GAD-7), Patient Health Questionnaire (PHQ-9), and Pittsburgh Sleep Quality Index (PSQI). Symptom networks were estimated using the Least Absolute Shrinkage and Selection Operator (LASSO) and Extended Bayesian Information Criterion (EBIC) in R software. Central and bridge symptoms were identified using expected influence (EI) and bridge expected influence (BEI). Network stability and accuracy were evaluated through bootstrap methods. The Network Comparison Test (NCT) was applied to analyze network differences across subgroups that vary by marital status and weight status. Results: Network analysis revealed that the strongest edge was the connection between "Daytime dysfunction" and "Low energy" (PSQI7-PHQ4), spanning different symptom communities. Another edge of high intensity was observed between "Worthlessness" and "Suicidal ideation" (PHQ6-PHQ9). "Trouble relaxing" (GAD4) and "Sad mood" (PHQ2) exhibited the highest EI values within the network. Meanwhile, "Daytime dysfunction" (PSQI7) and "Low energy" (PHQ4) showed the highest BEI values. Network comparison analysis revealed no significant differences across marital and weight status subgroups. Conclusion: This study is the first to explore the symptom interrelationships among anxiety, depression, and sleep problems in PCOS patients. Targeting these central symptoms (e.g., trouble relaxing, sad mood) and bridging symptoms (e.g., daytime dysfunction, low energy) may more effectively alleviate patients' overall psychological issues and potentially interrupt the spread of comorbid psychiatric conditions. The findings of this study can inform the development of personalized mental health management strategies for patients with PCOS.

Indexed as

anxietydepressionnetwork analysispolycystic ovary syndromesleep problems

Identifiers

PMID41696468
PMCPMC12900716

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.